Filtrovat podle Last updated date SelectpopředFrom - To Datum Datum ukončení Tento týden Tento měsíc Minulý týden Minulý měsíc Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationMedical devicesScientific adviceMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Výsledky (3794) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank EMA ends rolling review of CVnCoV COVID-19 vaccine following withdrawal by CureVac AG 12 Říjen 2021 News Human COVID-19 Vaccines A global approach to regulatory flexibility to increase manufacturing capacity during COVID-19 12 Říjen 2021 News Human COVID-19 Medicines Vaccines EMA receives application for marketing authorisation for Ronapreve (casirivimab / imdevimab) for treatment and prevention of COVID-19 11 Říjen 2021 News Human COVID-19 Paediatrics Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 5-7 October 2021 8 Říjen 2021 News Veterinary Medicines Highlights of Management Board – October 2021 meeting 8 Říjen 2021 News Corporate Additional manufacturing site for COVID-19 Vaccine Janssen 7 Říjen 2021 News Human COVID-19 Comirnaty and Spikevax: EMA recommendations on extra doses and boosters 4 Říjen 2021 News Human COVID-19 EMA receives application for marketing authorisation for Regkirona (regdanvimab) for treating patients with COVID-19 4 Říjen 2021 News Human COVID-19 Medicines EMA welcomes new Head of International Affairs 1 Říjen 2021 News Corporate Careers Governance EMA starts review of meningioma risk with nomegestrol- and chlormadinone-containing medicines 1 Říjen 2021 News Human Pharmacovigilance Referrals 1 … 53 54 55 56 57 Page 57 of 380 58 59 60 61 … 380
EMA ends rolling review of CVnCoV COVID-19 vaccine following withdrawal by CureVac AG 12 Říjen 2021 News Human COVID-19 Vaccines
A global approach to regulatory flexibility to increase manufacturing capacity during COVID-19 12 Říjen 2021 News Human COVID-19 Medicines Vaccines
EMA receives application for marketing authorisation for Ronapreve (casirivimab / imdevimab) for treatment and prevention of COVID-19 11 Říjen 2021 News Human COVID-19 Paediatrics
Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 5-7 October 2021 8 Říjen 2021 News Veterinary Medicines
Comirnaty and Spikevax: EMA recommendations on extra doses and boosters 4 Říjen 2021 News Human COVID-19
EMA receives application for marketing authorisation for Regkirona (regdanvimab) for treating patients with COVID-19 4 Říjen 2021 News Human COVID-19 Medicines
EMA starts review of meningioma risk with nomegestrol- and chlormadinone-containing medicines 1 Říjen 2021 News Human Pharmacovigilance Referrals